Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. EFFECT Other Notice of Effectiveness
  6. EFFECT Other Notice of Effectiveness
  7. SUPPL Other SUPPL
  8. SUPPL Other SUPPL
  9. 4 Shares withheld for taxes Chief Business Officer gave up 1,102 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 1,102 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief People Officer gave up 1,102 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Legal Officer gave up 1,102 shares (to pay taxes)
  13. 4 Shares withheld for taxes President & CEO gave up 5,550 shares (to pay taxes)
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. SC 13G Stake Amended Statement of Ownership
  17. UPLOAD Other SEC-generated Letter
  18. UPLOAD Other SEC-generated Letter
  19. S-3 Offering Registration Statement
  20. S-3 Offering Registration Statement

Page 8 of 28 · 549 filings